These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 7321740)

  • 1. [Alterations in the gene expression in tumors (author's transl)].
    Gamulin S
    Lijec Vjesn; 1981; 103(4-5):201-3. PubMed ID: 7321740
    [No Abstract]   [Full Text] [Related]  

  • 2. Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer.
    Ditzel HJ; Lyng MB
    Nat Clin Pract Oncol; 2008 Jul; 5(7):376-7. PubMed ID: 18506164
    [No Abstract]   [Full Text] [Related]  

  • 3. A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
    Yu K; Ganesan K; Miller LD; Tan P
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3288-96. PubMed ID: 16740749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mechanisms of estrogen receptor gene repression contribute to ER-negative breast cancer.
    Parl FF
    Pharmacogenomics J; 2003; 3(5):251-3. PubMed ID: 14583793
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
    Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
    Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.
    Ottaviano YL; Issa JP; Parl FF; Smith HS; Baylin SB; Davidson NE
    Cancer Res; 1994 May; 54(10):2552-5. PubMed ID: 8168078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to reverse resistance to hormonal therapy in human breast cancer.
    Weinberg OK; Marquez-Garban DC; Pietras RJ
    Drug Resist Updat; 2005 Aug; 8(4):219-33. PubMed ID: 16054421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoallelic amplification of estrogen receptor-alpha expression in breast cancer.
    Schuur ER; Weigel RJ
    Cancer Res; 2000 May; 60(10):2598-601. PubMed ID: 10825128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
    Levenson AS; Svoboda KM; Pease KM; Kaiser SA; Chen B; Simons LA; Jovanovic BD; Dyck PA; Jordan VC
    Cancer Res; 2002 Aug; 62(15):4419-26. PubMed ID: 12154049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
    Sieuwerts AM; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; Portengen H; Klijn JG; Foekens JA
    Clin Cancer Res; 2005 Oct; 11(20):7311-21. PubMed ID: 16243802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
    Kammori M; Izumiyama N; Hashimoto M; Nakamura K; Okano T; Kurabayashi R; Naoki H; Honma N; Ogawa T; Kaminishi M; Takubo K
    Int J Oncol; 2005 Nov; 27(5):1257-63. PubMed ID: 16211220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.
    Oh DS; Troester MA; Usary J; Hu Z; He X; Fan C; Wu J; Carey LA; Perou CM
    J Clin Oncol; 2006 Apr; 24(11):1656-64. PubMed ID: 16505416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.
    Girault I; Andrieu C; Tozlu S; Spyratos F; Bièche I; Lidereau R
    Cancer Lett; 2004 Nov; 215(1):101-12. PubMed ID: 15374639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response.
    Loi S; Piccart M; Sotiriou C
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):187-94. PubMed ID: 17088071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
    Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular aspects of different mechanisms of tamoxifen resistance].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL
    Bull Cancer; 1997 Jan; 84(1):69-75. PubMed ID: 9180863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
    Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
    Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.